The litigation centers on a securities class action filed in the United States District Court for the District of New Jersey. It names CEO Erez Meltzer and former CFO Ran Daniel as individual defendants, citing their authority over SEC filings and market communications between March 31, 2025, and April 17, 2026. The legal challenge follows a sharp 24.39% decline in Nano-X shares on April 20, 2026, triggered by the disclosure of a $17.5 million impairment charge and a broader manufacturing restructuring.
Nano-X Executives Face Securities Lawsuit Over Alleged Misstatements
Investors in Nano-X Imaging Ltd. face an August 11, 2026, deadline to seek lead plaintiff status in a class action lawsuit targeting senior management. The complaint alleges that top executives misled shareholders regarding manufacturing efficiency and operational sustainability during a volatile period for the company's stock.
At the heart of the case are the Sarbanes-Oxley certifications signed by Meltzer and Daniel. Plaintiffs contend these filings were materially false, asserting that both executives were aware—or recklessly disregarded—that the company's production operations were poorly aligned with actual demand. The complaint argues that while leadership touted operational improvements during quarterly earnings calls, they failed to disclose the underlying instability of the firm's Korean chip facility. Attorney Joseph E. Levi noted that the suit aims to hold officers accountable for discrepancies between public financial assurances and the reality of the company's manufacturing challenges.
Comments (0)
No comments yet. Be the first!